ENHANCE – China Phase 3 Trial for COPD LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory...
Latest articles
Pharma leaders support FDA amid mifepristone legal battle
Pharma leaders support FDA amid mifepristone legal battle Notably, Pfizer CEO Albert Bourla signed an industry letter supporting the FDA’s authority to regulate medicines in light of the decisions handed down Friday...
Emerce Conversion & Analytics: de cultuur van experimenteren
Emerce Conversion & Analytics Beter Bed is wakker! Zo heet de presentatie die Jaap van den Broek gaat geven op Emerce Conversion & Analytics op 20 april in Pakhuis de Zwijger in Amsterdam. In zijn rol als UX/CRO...
De 3 belangrijkste trends voor LinkedIn in 2023
Wat zal het nieuwe jaar ons brengen op LinkedIn? Er zijn al behoorlijk wat trendvoorspellingen gedaan, van online marketing, HR en tech, tot andere social media. Eén ding valt op, bedrijven humaniseren. Er is veel...
Rare cancer drug for young patients approved
A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA has approved new immunotherapy drug atezolizumab (Tecentriq) for patients with advanced alveolar soft...
New blood cancer treatment appears successful for most trial patients
A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 clinical trial. The blood cancer treatment has seen successful response rates in...
